This signaling pathway undergoes significant genomic alterations, and more β-catenin nuclear translocalization and co-localization with AR in CRPC compared to hormone naïve primary prostate cancer, which shows no alterations and less translocation [1]. This evidence concerns the gene AR and prostate carcinoma.